It was reported that RPL19 plays an important role in the progression of hepatocellular carcinoma (Rao et al., 2021), lung adenocarcinoma (Wei et al., 2023) and breast cancer (Hong et al., 2014). This evidence concerns the gene RPL19 and lung adenocarcinoma.